Press release
High Potency Active Pharmaceutical Ingredients (HPAPI) Market is Set to Reach US$ 36.83 Bn by year 2027-end, and Expected to Grow at a Whopping CAGR of 8.7%. - Transparency Market Research
The global ๐๐ข๐ ๐ก ๐๐จ๐ญ๐๐ง๐๐ฒ ๐๐๐ญ๐ข๐ฏ๐ ๐๐ก๐๐ซ๐ฆ๐๐๐๐ฎ๐ญ๐ข๐๐๐ฅ ๐๐ง๐ ๐ซ๐๐๐ข๐๐ง๐ญ๐ฌ (๐๐๐๐๐) ๐ฆ๐๐ซ๐ค๐๐ญ to reach US$ 36.83 Bn by 2027.ย The market is anticipated to expand at a CAGR of over 8.7% from 2019 to 2027.๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ :
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=748&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR
๐๐๐ญ๐๐ง๐ญ ๐๐ฑ๐ฉ๐ข๐ซ๐ฒ ๐จ๐ ๐๐ฅ๐จ๐๐ค๐๐ฎ๐ฌ๐ญ๐๐ซ ๐๐ซ๐ฎ๐ ๐ฌ ๐๐ซ๐จ๐ฉ๐๐ฅ ๐ญ๐ก๐ ๐๐ฅ๐จ๐๐๐ฅ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐จ๐ฐ๐ญ๐ก
Patent expiry and subsequent launch of generic versions is a lucrative opportunity for pharmaceutical companies to expand product portfolio and tap profitable market segments in this technology driven market.
Variousย biosimilarย have been approved in Europe, while the U.S. FDA has approved only one biosimilar to date. Increase in research and development activities and constant attempts toward mimicking brandedย biological drugsย would pave the way for introduction of cost-effective treatment alternatives.
Various blockbuster drugs are expected to loose patent protection in the near future, providing large opportunities in the biosimilar market. Avastin (bevacizumab), Herceptin (trastuzumab), Synagis (palivizumab), Erbitux (cetuximab), Humira (adalimumab), Remicade (infliximab), and Rituxan (rituximab) are some of the major drugs going off patent in the near future.
๐๐๐๐๐ข๐ง๐ ๐ฉ๐ฅ๐๐ฒ๐๐ซ๐ฌ:
Alkermes plc,Cambrex Corporation,Dr. Reddy's Laboratories,Lonza Group,Novasep,Novartis AG,Pfizer,Sigma-Aldrich Co. LLC.,WuXi AppTec,Bristol-Myers Squibb,F. Hoffmann-La Roche,Teva Pharmaceutical Industries,Eli Lilly and Company,Abbvie.
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง:
๐๐๐ ๐๐ฒ๐ฉ๐
Synthetic
Biological
๐๐๐ง๐ฎ๐๐๐๐ญ๐ฎ๐ซ๐ ๐๐ฒ๐ฉ๐
Captive
Contract
๐๐ซ๐ฎ๐ ๐๐ฒ๐ฉ๐
Branded
Generic
๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐ ๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง
Oncology Drugs
Anti-diabetic Drugs
Cardiovascular Drugs
Academic & Research Centers
Pharmaceutical Companies
Others
๐๐๐ฒ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ๐ฌ:
Inย April 2019, U.S. based Cambrex Corporation expanded its new facility high-potency API production in U.S.
Inย 2018, FDA approved 59 drugs, of that 42 were small molecules and 17 wereย biologicsย which accounts to aboutย 28.8%ย of total approvals which has risen fromย 26.1%ย from the yearย 2017. Few biologic drugs approved inย 2018ย are Trogarzo, Ilumya, Crysvita, Aimovig, Poteligeo, Emgality, Libtayo and Takyzyro.
๐๐๐ญ ๐๐ก๐ข๐ฌ ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐๐ฉ๐จ๐ซ๐ญ, ๐๐ง๐ฌ๐ญ๐๐ง๐ญ๐ฅ๐ฒ:
https://www.transparencymarketresearch.com/checkout.php?rep_id=748<ype=S&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR
๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐๐ง๐๐ฌ:
Emerging trends in the High Potency Active Pharmaceutical Ingredients market include the shift towards outsourcing manufacturing activities to specialized CDMOs, the development of innovative containment technologies to ensure worker safety, and the increasing focus on sustainability in HPAPI production processes.
๐๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐ญ๐ฎ๐๐ฒ ๐๐จ๐ข๐ง๐ญ๐ฌ:
Market size and growth projections
Segmentation analysis by service type, sourcing type, application, industry vertical, and region
Regional analysis highlighting key growth markets
Market drivers and challenges
Emerging trends shaping the market landscape
Future outlook and growth opportunities
๐ ๐ฎ๐ญ๐ฎ๐ซ๐ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค:
The future outlook for the HPAPIs market appears promising, with continued advancements in drug development and manufacturing techniques driving innovation and growth. Increasing collaborations between pharmaceutical companies and contract manufacturers are expected to further fuel market expansion.
๐๐ซ๐จ๐ฐ๐ฌ๐ ๐๐จ๐ซ๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ฒ ๐๐๐:
๐๐ ๐ซ๐ข๐๐ฎ๐ฅ๐ญ๐ฎ๐ซ๐๐ฅ ๐๐ก๐ซ๐๐๐๐๐ซ ๐๐๐ซ๐ค๐๐ญ- https://www.globenewswire.com/news-release/2023/05/24/2675437/0/en/Agricultural-Shredder-Market-Set-to-Achieve-USD-2-8-Billion-Revenue-by-2031-with-4-2-CAGR-TMR-Study.html
๐๐ข๐ฅ๐ข๐๐จ๐ง ๐๐ก๐จ๐ญ๐จ๐ฆ๐ฎ๐ฅ๐ญ๐ข๐ฉ๐ฅ๐ข๐๐ซ ๐๐๐ซ๐ค๐๐ญ- https://www.globenewswire.com/news-release/2023/05/24/2675365/0/en/Silicon-Photomultiplier-Demand-is-Predicted-to-Grow-at-an-8-3-CAGR-Reaching-US-274-4-Million-by-2031-Transparency-Market-Research-Analysis.html
๐๐๐จ๐ฎ๐ญ ๐๐ซ๐๐ง๐ฌ๐ฉ๐๐ซ๐๐ง๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก
Transparency Market Research, a globalย market research companyย registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
๐๐จ๐ง๐ญ๐๐๐ญ:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website:ย https://www.transparencymarketresearch.comย ย ย ย ย ย
Email:ย sales@transparencymarketresearch.com
Follow Us:ย LinkedIn|ย Twitter|ย Blogย |ย YouTube
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release High Potency Active Pharmaceutical Ingredients (HPAPI) Market is Set to Reach US$ 36.83 Bn by year 2027-end, and Expected to Grow at a Whopping CAGR of 8.7%. - Transparency Market Research here
News-ID: 3401093 • Views: โฆ
More Releases from Transparency Market Research
Gas Compressor Market Outlook 2036: Global Industry Expected to Reach US$ 41.0 B โฆ
The global gas compressor market was valued at US$ 23.2 Bn in 2025 and is projected to reach US$ 41.0 Bn by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036. This steady growth trajectory reflects the structural importance of gas compression systems across upstream, midstream, and downstream gas value chains. Rising natural gas consumption, expansion of pipeline and LNG infrastructure, and national energyโฆ
Anesthesia Drugs Market to be Worth USD 12.6 Bn by 2036 - By Drug / By Applicati โฆ
The global anesthesia drugs market was valued at US$ 7.6 billion in 2025 and is projected to reach US$ 12.6 billion by 2036, expanding at a compound annual growth rate (CAGR) of 4.7% from 2026 to 2036. This steady growth trajectory reflects the essential and non-substitutable role of anesthesia drugs in modern healthcare systems. As surgical interventions continue to rise globally-across both elective and emergency procedures-the demand for safe, effective,โฆ
Single-Atom Catalysts Market Size is Expected to Expand from US$ 177.8 Million t โฆ
The global single-atom catalysts (SACs) market is poised for remarkable growth as industries seek highly efficient, cost-effective, and sustainable catalytic solutions. Valued at US$ 177.8 million in 2025, the market is projected to reach US$ 1,000.2 million by 2036, expanding at a robust compound annual growth rate (CAGR) of 17.0% from 2026 to 2036. This rapid expansion reflects the growing importance of advanced catalysis in energy, chemicals, environmental protection, andโฆ
Non-specific Endonuclease Market to Reach USD 726.6 Million by 2036, Supported b โฆ
The non-specific endonuclease market is witnessing steady growth, driven by the expanding use of molecular biology tools across biotechnology, pharmaceuticals, diagnostics, and academic research. Non-specific endonucleases are enzymes that cleave nucleic acids without requiring a specific recognition sequence, making them highly valuable for applications such as DNA/RNA degradation, sample preparation, viscosity reduction, and contamination control. Their broad activity profile differentiates them from restriction enzymes and enables versatile usage across multipleโฆ
More Releases for Pharmaceutical
Metronidazole Market 2023 Latest Innovations and Outlook By Players - Hongyuan P โฆ
The Metronidazole Market 2023 study focuses on a global evaluation of information from the most recent market developments. The purpose of MarketsandResearch.biz is to offer the company's customers a comprehensive market overview to formulate development plans.
Designing of the report is done with the help of infographics, charts, and graphs. The report initially analyzes the various segments of the global Metronidazole market in a brief manner, which includes product types, applications.โฆ
Hyperthyroidism Treatment Market Analytical Overview and Future | Merck, Herbran โฆ
The Hyperthyroidism Treatment market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with developmentโฆ
Mevastatin Market Is Booming Worldwide |Zhejiang Hisun Pharmaceutical, Guangdong โฆ
Global Mevastatin Market Sizeย research report 2022 offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. This study provides information about the sales and revenue during the historic and forecasted period of (2022 to 2028). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value forโฆ
Global Specialty Pharmaceutical Market Driving Future Growth on Specialty Pharma โฆ
Global Specialty Pharmaceutical Industry Synopsis:
The Specialty Pharmaceutical Market report provides a detailed analysis of this business space. The market is analyzed in terms of production as well as consumption. Based on the production aspect, the report includes particulars pertaining to the manufacturing processes of the product, alongside revenue and gross margins of the respective manufacturers.
The Global Specialty Pharmaceutical Market will reach xxx Million USD in 2020 with CAGR xx%โฆ
Metronidazole Market to 2023 (+5% CAGR Expected) Top Player Profiles โ Hongyua โฆ
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR
Scope of the Report:
This report focuses on the Metronidazole in global market, especially inโฆ
Metronidazole Market by Top Key Participant Hongyuan Pharmaceutical, Yinhe Aarti โฆ
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Get Sample Copy of this Report @ https://www.researchbeam.com/global-metronidazole-2018-by-manufacturers-regions-type-and-application-forecast-to-2023-market/request-sample?utm_source=Anil
Scope of the Report:
This report focuses on the Metronidazole in global market, especially in Northโฆ
